1-naphthylamine has been researched along with HIV Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rabkin, JG; Rabkin, R; Wagner, G | 1 |
Charness, WE; Ferrando, SJ; Goldman, JD | 1 |
2 trial(s) available for 1-naphthylamine and HIV Infections
Article | Year |
---|---|
Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
Topics: 1-Naphthylamine; Affect; Antidepressive Agents; CD4 Lymphocyte Count; Comorbidity; Depressive Disorder; Female; HIV Infections; Humans; Immunity; Killer Cells, Natural; Leukocyte Count; Male; Psychiatric Status Rating Scales; Sertraline; T-Lymphocyte Subsets; T-Lymphocytes; Treatment Outcome | 1994 |
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.
Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders | 1997 |